Prolonged COVID-19 infection in a child with lymphoblastic non-Hodgkin lymphoma: which is the best management?
Tumori
; 108(6): NP1-NP4, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-1582700
ABSTRACT
During the coronavirus disease 2019 (COVID-19) pandemic, oncologists have managed patients at higher risk of having a severe course of this infection. This raises new questions about their correct management, as well as the difficulty of distinguishing tumor/treatments complications from those related to COVID-19. We report a case of an 11-year-old boy undergoing treatment for T-cell lymphoblastic lymphoma who experienced a prolonged COVID-19 course. Oncologic therapy was continued without significant changes compared to the initially planned treatment. No relevant complications occurred. COVID-19 convalescent plasma was administered, resulting in a positive antibody titer after 24 days.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Child
/
Humans
/
Male
Language:
English
Journal:
Tumori
Year:
2022
Document Type:
Article
Affiliation country:
03008916211067825
Similar
MEDLINE
...
LILACS
LIS